Home › Funds › ATLAS CAPITAL ADVISORS INC. › ELV
ATLAS CAPITAL ADVISORS INC. position in ELV
ELEVANCE HEALTH · Health Care
ATLAS CAPITAL ADVISORS INC. reported holding 3,648 shares of ELV (ELEVANCE HEALTH) in its Q3 2026 13F filing — a position valued at US$9.6M, representing 0.92% of its reported portfolio and ranking #26 among its reported holdings. ATLAS CAPITAL ADVISORS INC. has disclosed ELV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-09 · Source: SEC EDGAR Form 13F-HR
How ATLAS CAPITAL ADVISORS INC.'s ELV position evolved
ATLAS CAPITAL ADVISORS INC. first disclosed a stake in ELV in Q3 2023 at 4,451 shares (US$1.9M). The position peaked in Q3 2026 at 3,648 shares, worth US$9.6M. Across 11 filings, ATLAS CAPITAL ADVISORS INC. increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 3,648 shares valued at US$9.6M — an increase of 93 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.45K | $1.94M | New |
| Q4 2023 | 4.62K | $2.18M | Add |
| Q1 2024 | 4.59K | $2.38M | Reduce |
| Q3 2024 | 4.55K | $2.37M | Reduce |
| Q4 2024 | 3.66K | $1.35M | Reduce |
| Q1 2025 | 3.66K | $1.59M | Hold |
| Q2 2025 | 3.54K | $1.38M | Reduce |
| Q4 2025 | 3.50K | $1.23M | Reduce |
| Q1 2026 | 3.50K | $1.03M | Hold |
| Q2 2026 | 3.56K | $1.37M | Add |
| Q3 2026 | 3.65K | $9.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on ATLAS CAPITAL ADVISORS INC.
FAQ
How long has ATLAS CAPITAL ADVISORS INC. held ELV?
ATLAS CAPITAL ADVISORS INC. has disclosed ELV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is ATLAS CAPITAL ADVISORS INC.'s current position in ELV?
As of Q3 2026, ATLAS CAPITAL ADVISORS INC. holds 3.65K shares of ELV (ELEVANCE HEALTH), valued at $9.59M, representing 0.92% of its reported portfolio and ranking #26.
Has ATLAS CAPITAL ADVISORS INC. been buying or selling ELV?
In the latest 13F filing (Q3 2026), ATLAS CAPITAL ADVISORS INC. increased its position in ELV. The position peaked in Q3 2026 at 3.65K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.